INmune Bio, Inc. (INMB) Tops Q1 EPS by 18c

INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.36), $0.18 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $38 thousand.

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
• Ennis (EBF) Reports In-Line Q1 EPS
• Carnival shares drop despite earnings beat on weak guidance